Cargando…
Genetic Modifications That Expand Oncolytic Virus Potency
Oncolytic viruses (OVs) are a promising type of cancer therapy since they selectively replicate in tumor cells without damaging healthy cells. Many oncolytic viruses have progressed to human clinical trials, however, their performance as monotherapy has not been as successful as expected. Importantl...
Autores principales: | Cristi, Francisca, Gutiérrez, Tomás, Hitt, Mary M., Shmulevitz, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826539/ https://www.ncbi.nlm.nih.gov/pubmed/35155581 http://dx.doi.org/10.3389/fmolb.2022.831091 |
Ejemplares similares
-
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
por: Cristi, Francisca, et al.
Publicado: (2023) -
Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023) -
Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022) -
Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
por: Abdulal, Rwaa H., et al.
Publicado: (2023) -
Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
por: Howard, Faith, et al.
Publicado: (2022)